Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy
Authors
Keywords
-
Journal
Cancer Nanotechnology
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-14
DOI
10.1186/s12645-020-00072-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance
- (2019) Yu Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
- (2019) Weimin Wang et al. NATURE
- Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma
- (2019) J. Milburn Jessup et al. Human Vaccines & Immunotherapeutics
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation
- (2018) Wanjing Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic anticancer agents cause HMGB1 release in vivo
- (2018) Peng Liu et al. OncoImmunology
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells
- (2017) Yulia Malinovskaya et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth
- (2017) Hao Yang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability
- (2017) Zhengjun Gao et al. Nature Communications
- Comparison of Three Isolation Techniques for Human Peripheral Blood Mononuclear Cells: Cell Recovery and Viability, Population Composition, and Cell Functionality
- (2016) Hendrika W. Grievink et al. BIOPRESERVATION AND BIOBANKING
- Heterogeneity of liver cancer and personalized therapy
- (2016) Liang Li et al. CANCER LETTERS
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
- (2016) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles
- (2016) Marilena Hadjidemetriou et al. Nanoscale
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Dendritic Cells and Cancer Immunity
- (2016) Alycia Gardner et al. TRENDS IN IMMUNOLOGY
- Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma
- (2016) MASANORI KAWANO et al. Oncology Letters
- Comparison of Three Isolation Techniques for Human Peripheral Blood Mononuclear Cells: Cell Recovery and Viability, Population Composition, and Cell Functionality
- (2016) Hendrika W. Grievink et al. Biopreservation and Biobanking
- Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
- (2015) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin
- (2015) Ashay Jain et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Immunogenic cell death
- (2015) Abhishek D. Garg et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells
- (2015) Rong Sun et al. JOURNAL OF CONTROLLED RELEASE
- Liver cancer: Approaching a personalized care
- (2015) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy
- (2015) Sylvain Ladoire et al. OncoImmunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started